Catalyst Wire Dossier Catalyst Wire Dossier

ZELAPAR

SELEGILINE HYDROCHLORIDE · Bausch Health US, LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ZELAPAR, covering 2006-06-14 to 2023-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Selegiline to Zelapar Switch Study in Parkinson Disease Patients [Phase 4]

See pricing